PortfoliosLab logoPortfoliosLab logo
Ultralife Corporation (ULBI)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US9038991025
CUSIP
903899102
IPO Date
Dec 23, 1992

Highlights

Market Cap
$108.58M
Enterprise Value
$107.49M
EPS (TTM)
-$0.35
Total Revenue (TTM)
$191.16M
Gross Profit (TTM)
$46.02M
EBITDA (TTM)
-$1.59M
Year Range
$4.07 - $9.52
ROA (TTM)
-2.72%
ROE (TTM)
-4.54%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ultralife Corporation

Often compared with ULBI:
ULBI vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Ultralife Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Ultralife Corporation (ULBI) has returned 13.99% so far this year and 21.19% over the past 12 months. Over the last ten years, ULBI has returned 2.49% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Ultralife Corporation

1D
6.36%
1M
14.99%
YTD
13.99%
6M
-4.40%
1Y
21.19%
3Y*
17.49%
5Y*
-4.67%
10Y*
2.49%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 23, 1992, ULBI's average daily return is +0.08%, while the average monthly return is +1.14%. At this rate, your investment would double in approximately 5.1 years.

Historically, 46% of months were positive and 54% were negative. The best month was Jan 2000 with a return of +89.9%, while the worst month was Oct 2002 at -40.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ULBI closed higher 45% of trading days. The best single day was Jul 27, 2023 with a return of +52.5%, while the worst single day was Sep 27, 2004 at -30.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202611.54%-11.13%14.99%13.99%
20251.74%-17.28%-14.19%-16.73%48.88%34.63%-11.25%-12.86%-1.80%3.08%-19.06%0.53%-23.22%
20243.67%27.86%-2.54%32.80%-0.51%-8.76%12.81%-12.69%-13.58%-6.97%-8.80%-2.87%9.24%
20235.44%-0.74%-0.50%4.48%0.24%14.96%69.21%15.63%3.06%-23.98%0.94%-8.95%76.68%
2022-11.42%0.37%0.00%-8.01%-2.23%-5.80%-1.54%11.61%-3.80%2.91%-15.56%-7.66%-36.09%
2021-9.27%16.01%21.59%-4.59%15.57%-8.21%-5.25%3.15%-13.06%-12.08%-14.54%12.90%-6.65%

Benchmark Metrics

Ultralife Corporation has an annualized alpha of 12.16%, beta of 0.80, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since December 24, 1992.

  • This stock participated in 104.57% of S&P 500 Index downside but only 57.21% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
12.16%
Beta
0.80
0.05
Upside Capture
57.21%
Downside Capture
104.57%

Return for Risk

Risk / Return Rank

ULBI ranks 52 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


ULBI Risk / Return Rank: 5252
Overall Rank
ULBI Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 5353
Sortino Ratio Rank
ULBI Omega Ratio Rank: 5151
Omega Ratio Rank
ULBI Calmar Ratio Rank: 5151
Calmar Ratio Rank
ULBI Martin Ratio Rank: 4949
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Ultralife Corporation (ULBI) and compare them to a chosen benchmark (S&P 500 Index).


ULBIBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.35

0.90

-0.54

Sortino ratio

Return per unit of downside risk

0.94

1.39

-0.44

Omega ratio

Gain probability vs. loss probability

1.11

1.21

-0.10

Calmar ratio

Return relative to maximum drawdown

0.43

1.40

-0.96

Martin ratio

Return relative to average drawdown

0.76

6.61

-5.85

Explore ULBI risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Ultralife Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ultralife Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ultralife Corporation was 92.90%, occurring on Oct 18, 2002. The portfolio has not yet recovered.

The current Ultralife Corporation drawdown is 73.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.9%Oct 2, 19951776Oct 18, 2002
-54.43%Jan 22, 199380May 17, 1993256May 20, 1994336
-41.74%Nov 22, 199452Feb 6, 1995157Sep 20, 1995209
-20%May 27, 199421Jun 27, 199473Oct 10, 199494
-13.21%Dec 24, 19924Dec 30, 19926Jan 8, 199310

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ultralife Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Ultralife Corporation is priced in the market compared to other companies in the Electrical Equipment & Parts industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ULBI relative to other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ULBI in comparison with other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items